Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
Conditions: Uveal Melanoma; Ocular Melanoma Interventions: Drug: Pembrolizumab; Drug: Olaparib Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Merck Sharp & Dohme LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eye Cancers | Melanoma | Research | Skin Cancer | Uveal Melanoma